Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Looking At Outside Research Alliances Through Advisory Committees

Executive Summary

FDA's Pharmaceutical Science/Nonclinical Studies Advisory Subcommittee is being watched as a model for using advisory committees to expand FDA's collaboration with outside sources.

You may also be interested in...



CDER Office of Testing & Research

Director James MacGregor, PhD, is leaving Center for Drug Evaluation & Research in January to join the National Center for Toxicological Research as deputy director-Washington operations. MacGregor has been on a four-month assignment as the CDER science leveraging coordinator (1"The Pink Sheet" Sept. 11, p. 24). OTR Acting Deputy Director Ajaz Hussain, PhD, has been serving as director of OTR

CDER Office of Testing & Research

Director James MacGregor, PhD, is leaving Center for Drug Evaluation & Research in January to join the National Center for Toxicological Research as deputy director-Washington operations. MacGregor has been on a four-month assignment as the CDER science leveraging coordinator (1"The Pink Sheet" Sept. 11, p. 24). OTR Acting Deputy Director Ajaz Hussain, PhD, has been serving as director of OTR

Cardiotoxicity, Vasculitis And PET Biomarker Groups To Be Formed By FDA

Vasculitis will be the focus of one of the three expert working groups endorsed by FDA's Advisory Committee for Pharmaceutical Science/Nonclinical Studies Subcommittee at its March 9 meeting.

UsernamePublicRestriction

Register

PS143249

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel